Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin degludec vs insulin glargine in type 2 diabetes (BEGIN: BB)
NCT00972283Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Sep 2009
- Primary completion
- Oct 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 12
01
Overview
A Phase 3 trial of insulin degludec in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Sep 2009; status: completed.
02
Drugs
insulin degludec
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00972283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00972283.